在复杂的先天性心脏病中组合的皮下植入式心脏转换器除器和起器设备:一个单一中心的经验研究
Berardo Sarubbi1, Giovanni Domenico Ciriello2, Giovanni Papaccioli2
1Monaldi Hospital, Via Leonardo Bianchi, 80131, Naples, Italy. berardo.sarubbi@ospedalideicolli.it.
概括
皮下植入式心脏转心器除器 (S-ICD) 是患有心脏起器 (PM) 的先天性心脏病 (CHD) 患者的安全选择. 这项研究发现,S-ICD植入在复杂心脏病患者中是有效的,避免了与透静脉系统相关的风险.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 电力生理学 电力生理学
背景情况:
- 皮下植入式心脏转动器除器 (S-ICD) 是为患有先天性心脏病 (CHD) 的患者,在不需要节奏时面临突然心脏死亡 (SCD) 风险.
- 取决于心脏起器 (PM) 的CHD患者后来可能需要心脏转换器除器,这对S-ICD使用提出了独特的挑战.
- 在复杂的CHD患者中,S-ICD的安全性和医生建议尚未明确,这些患者之前有PM植入.
研究的目的:
- 审查S-ICD在复杂的CHD患者之前PM植入的数据和指示.
- 讨论S-ICD在这个特定患者群体中的临床有用性.
主要方法:
- 对S-ICD Monaldi护理登记数据的回顾性审查.
- 对11名连续接受S-ICD后PM植入的复杂心脏病患者的分析 (2015年2月 - 2022年10月).
- 评估患者的遵守,并发症和随访数据.
主要成果:
- 之前有PM植入的11名复杂心脏病患者 (平均年龄为40.4岁) 接受了S-ICD植入.
- 平均随访时间为25.5个月,所有患者都表现出良好的设备合规性.
- 没有观察到感染或皮肤侵蚀等并发症.
结论:
- 对于已经配备PM设备的复杂CHD患者来说,S-ICD植入是一种安全的替代方案.
- 通过S-ICD避免了升级到输血ICD系统的风险,例如废弃的或提取.
- 在这个群体中对S-ICD测试和编程的具体考虑需要进一步关注.
相关概念视频
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiopulmonary Resuscitation III: AED Use
34
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
34
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Dysrhythmias VI: Management of Dysrhythmias
17
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
17
Cardiac Catheterization IV: Nursing Management
31
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
31


